Arecor Therapeutics (AREC)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 41.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 160.00
  • 52 Week Low: 38.00
  • Currency: UK Pounds
  • Shares Issued: 37.76m
  • Volume: 701
  • Market Cap: £15.67m
  • Beta: 0.01

Latest ShareCast News

Arecor enters formulation partnership with Skye Bioscience

By Josh White

Date: Monday 19 May 2025

(Sharecast News) - Arecor Therapeutics announced on Monday that it has entered a formulation development partnership with Skye Bioscience to create an improved version of Skye's investigational obesity treatment, nimacimab.

Arecor enters collaboration with unnamed global pharma major

By Josh White

Date: Wednesday 26 Mar 2025

(Sharecast News) - Arecor Therapeutics announced on Wednesday that it has entered into a new collaboration with a major global pharmaceutical company to apply its proprietary Arestat technology platform to develop an enhanced formulation of the partner's proprietary product.

Revenue higher, cash reserves fall at Arecor

By Josh White

Date: Monday 03 Feb 2025

(Sharecast News) - Arecor Therapeutics reported total full-year revenue of £5.1m in a trading update on Monday, up from £4.6m in 2023.

Arecor to wind up operations at Tetris Pharma su... 10-Jan-2025 ShareCast
Arecor upbeat on signing of exclusive licensing ... 30-Dec-2024 ShareCast
Arecor Therapeutics shares tank on funding update 10-Jun-2024 ShareCast
Arecor subsidiary Tetris launching Ogluo in the ... 29-Feb-2024 ShareCast
Arecor appoints new commercial manager to Tetris... 03-Jan-2024 ShareCast
Arecor inks co-development deal with global medi... 04-Dec-2023 ShareCast
Arecor gets milestone payment from Arestat partner 17-Nov-2023 ShareCast
Arecor inks partnership with unnamed pharma giant 17-Aug-2023 ShareCast
Arecor Therapeutics appoints new chief business ... 05-Apr-2023 ShareCast
Arecor Therapeutics begins type-2 diabetes trial 22-Mar-2023 ShareCast
Arecor granted three patents in US, India 16-Feb-2023 ShareCast
Arecor ends 2022 in line with forecasts 19-Jan-2023 ShareCast
Arecor's Tetris launches 'Ogluo' in Austria 04-Jan-2023 ShareCast
Arecor inks formulation study deal with 'leading... 10-Nov-2022 ShareCast
Arecor's Tetris launches hypoglycaemia treatment... 01-Nov-2022 ShareCast
Arecor gets two EU patents for adalimumab formul... 09-Aug-2022 ShareCast
Expectations exceeded for Arecor's two lead clin... 23-May-2022 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

AREC Market Data

Currency UK Pounds
Share Price 41.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 160.00
52 Week Low 38.00
Volume 701
Shares Issued 37.76m
Market Cap £15.67m
Beta 0.01

AREC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.35% below the market average47.35% below the market average47.35% below the market average47.35% below the market average47.35% below the market average
6.38% above the sector average6.38% above the sector average6.38% above the sector average6.38% above the sector average6.38% above the sector average
Price Trend
92.98% below the market average92.98% below the market average92.98% below the market average92.98% below the market average92.98% below the market average
70.21% below the sector average70.21% below the sector average70.21% below the sector average70.21% below the sector average70.21% below the sector average
Income Not Available
Growth
41.76% above the market average41.76% above the market average41.76% above the market average41.76% above the market average41.76% above the market average
35.48% above the sector average35.48% above the sector average35.48% above the sector average35.48% above the sector average35.48% above the sector average

AREC Dividends

No dividends found

Trades for 23-May-2025

Time Volume / Share Price
11:42 698 @ 42.94p
10:23 3 @ 43.00p

AREC Key Personnel

CEO Sarah Jennifer Howell
CFO David Ellam

Top of Page